Completed
Study of Regorafenib as a 3rd-line or Beyond Treatment for Gastrointestinal Stromal Tumors (GIST)
NCT01271712
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
- Locations
-
- Scottsdale, Arizona, United States
- Evanston, Illinois, United States
- Skokie, Illinois, United States
- Boston, Massachusetts, United States